Skip to main content

2025 turnover up +16% at constant exchange rates

2025 turnover up +16% at constant exchange rates 2025 EBITDA target reconfirmed despite curtailment impact Continued rollout of the SPRING transformation plan Fourth‑quarter (Q4) 2025 turnover at 166.3 million euros (+8% at constant exchange rates)Energy Sales: Turnover amounts to 78.5 million euros, down -15% at constant exchange rates, mainly impacted by higher‑than‑expected curtailment in Brazil, a price effect resulting from the end of short‑term contracts previously signed at high price levels1, and a less favorable EUR/BRL exchange rate Services for third‑party clients2: Turnover totals 87.8 million euros, up +42% at constant exchange rates, driven by the combined performance of Construction for third‑party clients (+43%) and Operation & Maintenance (+18%)Achievement of the operating and construction capacity targetCapacity...

Continue reading

FFW Corporation Announces Earnings for the Quarter Ended December 31, 2025

WABASH, Ind., Jan. 28, 2026 (GLOBE NEWSWIRE) — FFW Corporation (the “Corporation”) (OTCID: FFWC) (01/27/2026 Close: $47.65), parent corporation of Crossroads Bank (the “Bank”), announced earnings for the quarter ended December 31, 2025. For the three months ended December 31, 2025, the Corporation reported net income of $1,617,000 or $1.48 per common share compared to $1,440,000 or $1.29 per common share for the three months ended December 31, 2024. Net interest income for the three months ended December 31, 2025 was $4,664,000,000 compared to $3,994,000 for the three months ended December 31, 2024. Credit loss expense was $100,000 for the three months ended December 31, 2025 and $75,000 for the three months ended December 31, 2024. Total noninterest income was $1,161,000 for the three months ended December 31, 2025 compared to...

Continue reading

Correction: Eimskip: Management Financial Report – Fourth quarter and full year 2025 results

Headline from previous release corrected Highlights of Q4 2025 results The quarter results were shaped by challenging external conditions. Revenue amounted to EUR 201.4 million, decreasing by EUR 25.8 million or 11.4% compared with the fourth quarter of 2024.Volume in Liner decreased by 6.1% during the quarter. There was a significant year-over-year increase in imports to Iceland, driven primarily by a sharp rise in vehicle imports. This was offset by a decline in exports from Iceland due to substantially lower volume of industrial cargo.Volume in Trans-Atlantic were solid, although lower than the exceptionally strong levels in Q4 2024. Reduced capacity in Norway also impacted volumes, as one out of four reefer vessels was out of operation for the entire quarter due to docking. A substantial decline in global freight rates affected international...

Continue reading

Progressive Reports December 2025 Results

MAYFIELD VILLAGE, OHIO, Jan. 28, 2026 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for the month and quarter ended December 31, 2025:  December Quarter(millions, except per share amounts and ratios; unaudited)   2025     2024     Change   2025     2024     ChangeNet premiums written $       6,313   $       5,964     6   % $    19,508   $    18,105     8 %Net premiums earned $       7,121   $       6,717     6   % $    21,093   $    19,144     10 %Net income $       1,147   $          942     22   % $       2,951   $       2,356     25 %Per share available to common shareholders $         1.95   $         1.60     22   % $         5.02   $         4.01     25 %Total pretax net realized gains (losses) on securities $          168   $        (140 )   (220 ) % $         ...

Continue reading

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

Interim results from Phase 2b clinical trial of RAD 101 showed 92% of evaluable participants met the primary endpoint of MRI concordance in imaging study of patients with brain metastases  Interim data from additional Cohorts of the Phase 1 clinical trial of RAD 202 and RAD 204 in advanced solid tumors are expected in mid-2026 Cash and cash equivalents of approximately $34.52 million provide runway into 2027 to advance pipeline of high value radiotherapeutic programs through key clinical and regulatory milestones SYDNEY, Jan. 28, 2026 (GLOBE NEWSWIRE) — Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, today announced financial results for the first six months...

Continue reading

Teva Innovative Portfolio and Consistent Execution of Pivot to Growth Strategy Deliver Third Consecutive Year of Growth; Pipeline Positioned to Unlock Significant Value Potential

Teva delivers 3 consecutive years of growth – 2025 revenues of $17.3 billion, an increase of 4% year-over-year (YoY) in U.S. dollars, or 3% in local currency (LC) terms, compared to 2024. Excluding Japan BV, revenues increased 5% YoY in LC. Key Innovative brands continued to drive growth and provide value for patients, with 2025 revenues surpassing $3 billion, +35% YoY in LC:AUSTEDO® global revenues of $2.26 billion, growing 34% YoY in LC.AJOVY® global revenues of $673 million, up 30% YoY in LC. UZEDY® revenues of $191 million, up 63% YoY in LC; underscoring Teva’s commitment to drive new advances in neuroscience:Fastest growing long-acting injectable (LAI)1 FDA expanded indication approval for Bipolar 1 Disorder.Q4 2025 marks the first quarter in which these key brands collectively delivered ~$1 billion of revenues.Generics...

Continue reading

Stifel Reports Record Full Year Results, Announces 11% Common Stock Dividend Increase and Three-For-Two Stock Split

ST. LOUIS, Jan. 28, 2026 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today reported net revenues of $1.56 billion for the three months ended December 31, 2025, compared with $1.36 billion a year ago. Net income available to common shareholders was $255.0 million, or $2.31 per diluted common share, compared with $234.7 million, or $2.09 per diluted common share for the fourth quarter of 2024. Non-GAAP net income available to common shareholders was $290.0 million, or $2.63 per diluted common share for the fourth quarter of 2025. Net revenues of $5.53 billion for the year ended December 31, 2025, compared to $4.97 billion a year ago. Net income available to common shareholders was $646.5 million, or $5.87 per diluted common share, compared with $694.1 million, or $6.25 per diluted common share in 2024. Non-GAAP net income...

Continue reading

Fidelity D & D Bancorp, Inc. Reports 2025 Financial Results

DUNMORE, Pa., Jan. 28, 2026 (GLOBE NEWSWIRE) — Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) and its banking subsidiary, The Fidelity Deposit and Discount Bank (“the Company”), announced its unaudited, consolidated financial results for the three and twelve month periods ended December 31, 2025. Unaudited Financial Information Net income recorded for the year ended December 31, 2025 was $28.2 million, or $4.86 diluted earnings per share, compared to $20.8 million, or $3.60 diluted earnings per share, for the year ended December 31, 2024. The $7.4 million, or 36% increase in net income resulted primarily from the $10.8 million increase in net interest income and $1.6 million increase in non-interest income partially offset by a $3.3 million increase in non-interest expenses for 2025 compared to 2024. Net income for...

Continue reading

ScottsMiracle-Gro Reports First Quarter Results and Advancement of Key Strategic Initiatives

Announces divestiture plan for Hawthorne Unveils new multi-year share repurchase program to commence in late 2026 MARYSVILLE, Ohio, Jan. 28, 2026 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today reported results for the first quarter ended December 27, 2025. The Company also announced that it is in advanced discussions for the sale of its Hawthorne subsidiary to Vireo Growth, Inc., with an anticipated closing in the fiscal second quarter. In conjunction with the pending divestiture, effective in its first quarter of fiscal 2026, the Company classified its results of operations for all periods presented to reflect the Hawthorne business as a discontinued operation. The Company is reaffirming its fiscal 2026 guidance, as the classification...

Continue reading

DoubleDown Interactive to Report 2025 Fourth Quarter Results on February 11 and Host Conference Call and Webcast

SEOUL, South Korea, Jan. 28, 2026 (GLOBE NEWSWIRE) — DoubleDown Interactive Co., Ltd. (NASDAQ: DDI) (“DoubleDown” or the “Company”), a leading developer and publisher of digital games on mobile and web-based platforms, announced today that it will release its 2025 fourth quarter financial results after the market closes on Wednesday, February 11, 2026, and host a conference call and simultaneous webcast at 5:00 p.m. ET (2:00 p.m. PT) that day. Both the call and webcast are open to the general public. On the call, DoubleDown management will review the Company’s financial results and provide a business update, followed by a question-and-answer session. To access the call, please use the following link: DoubleDown Fourth Quarter 2025 Earnings Call. After registering, an email will be sent, including dial-in details and a unique conference...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.